Absolute and relative (ratio absolute tumor volume to gland volume) tumor volumes were visually estimated in 528 prostatectomy specimens. Surveying a mean post-surgical follow-up of 49 months, both parameters were analyzed regarding their aptitude for prognostication. We found relative tumor volumes exceeding 25% to independently predict biochemical recurrence reflected by postsurgical prostate-specific antigen progression, which was also determined to be increased to 28% when absolute tumor volumes exceeded 10 cm 3 . However, this cutoff failed to be an independent prognosticator. Because the visual estimation of both parameters can easily be performed, they are felt to be formidable candidates for deriving prognostic information during routine procedures.
Introduction
Assessing the prognosis of patients after radical prostatectomy is part of the daily oncologic practice. Established prognostic factors, like lymph node status, tumor stage, Gleason score, surgical margins and preoperative prostate-specific antigen (PSA) value, provide information for predicting clinical outcome of the tumor disease. The decision as to whether or not adjuvant therapeutic approaches should be advocated is largely based on prognostic parameters known to independently predict tumor-free survival after radical prostatectomy. The knowledge of such prognostic factors allows the clinician to choose between various treatment strategies to improve the patient's long-time survival. Currently, there is a competition between various additional potential prognostic factors (e.g., E-cadherin, Ki-67, neuroendocrine differentiation, cell cycle regulation proteins, HER-2/neu). However, evaluation of these parameters has not finished yet. [1] [2] [3] [4] [5] There is general agreement that the Gleason score, any infiltration of the prostate capsule and/or seminal vesicles, and the status of surgical margins should be described by the pathologist. If lymphadenectomy has been carried out, details about the lymph node status should additionally be provided.
There is a great deal of controversy about the aptitude of the tumor volume for predicting prognostic outcome. 1, 6, 7 A high tumor volume was found to be associated with some adverse factors of prognosis (e.g., high preoperative PSA value, high Gleason score, extraprostatic spread of cancer, positive section margins). The tumor volume was also found to be a valid criterion for differentiating clinically significant and insignificant prostate carcinoma. 8 However, some analyses failed to prove any independent influence on biochemical-free survival. 6, 9, 10 In addition, there are considerable technical difficulties in determining the 'real' tumor volume in prostatectomy specimens owing to the uncertainty about which parameters should be measured (e.g., the total volume of all cancer foci, the volume of the biologically most significant lesion or combinations of these parameters) and how the measurements should be carried out. 11, 12 Currently, computer-assisted morphometric approaches represent the 'Gold standard'; 6 however at present, these methods are time-and cost-intensive and the technical devices required are not always available. 11, [13] [14] [15] We investigated the prognostic impact of the visually estimated tumor volume with respect to its aptitude for predicting the PSA-free survival in a total of 528 patients treated by radical prostatectomy due to prostate cancer.
Methods

Patients
Our study comprises data pooled from a total of 833 patients diagnosed with prostate cancer assigned to range from cT1 to cT3. Patients were treated by radical prostatectomy at the Vivantes-Hospitals Am Urban and Friedrichshain from January 1996 to May 2003. Among these patients, we identified a sub-population comprising 528 patients who did not undergo neoadjuvant or adjuvant androgen deprivation. Furthermore, all pathologic criteria were determined including visual estimation of tumor volumes and the prostate volumes. In all individuals chosen to be investigated in our study, diagnosis of cancer was exclusively based on multi-core biopsies. Any individuals who had experienced previous transurethral resection were strictly excluded from our study because of the manipulation of neoplastic and non-neoplastic tissue volumes by these procedures, which might be expected to affect the results.
Pathologic staging and estimation of the tumor volume
Following inking of resection margins, prostatectomy specimens were fixed in a freshly prepared solution of 5% formalin. Following removal of both seminal vesicles, the prostate volume was determined by means of the water replacing method. Subsequently, seminal vesicles were processed separately. The apex and the base of the prostate gland were processed by means of serial sections perpendicular to the resection level of the gland. After the remaining parts of the gland were transversely sectioned at 4 mm intervals, whole-mount sections were prepared. Thus, apex, base, both seminal vesicles and the remaining tissue of the gland were completely embedded for subsequent histomorphological assessment. Extracapsular tumor spread, positive margins, the invasion of the seminal vesicles and Gleason score (as primary and secondary tumor pattern) were documented. Staging was performed according to the TNM classification from 2002 (6th edition) after histopathological assessment of pelvine lymph nodes.
Visual estimation of the absolute and the relative tumor volumes was carried out by Volker Loy (PhD, head of the Department of Pathology, Vivantes-Clinic am Urban, Berlin). Briefly, whole-mount sections of the entire gland were histopathologically assessed at scanning magnification ( Â 4). Foci and areas of cancer spread were encircled with a pen on each tumor-bearing slide. Considering all whole-mount sections by this approach, the absolute tumor volume was visually estimated. This was carried out by the following approximation: each tumor-bearing slide was assigned and estimated area of tumor spread by superimposing transparent grid, which was subdivided into several small squares with each square measuring exactly 1 mm . If the preceding and the following slide were devoid of any tumor foci, approximate calculation of the tumor volume of this twodimensional tumor focus was based on multiplication of this estimated area (in mm 2 ) by 5 mm, which exactly corresponded to the height of the plastic capsule used for embedding whole-mount sections. If there was continuous tumor spread in successive slides, each slide was assigned an estimated area of tumor spread (in mm 2 ), and again this area multiplicated by 5 mm, thus yielding approximate volumes (in mm 3 ) occupying the space of prostatic tissue between two adjacent tumor-bearing slides. Finally, all separately estimated tumor volumes (in mm 3 ) were added up when review of all wholemount sections was completed. The relative tumor volume was calculated by the following equation: (100%: volume of total gland determined by means of water replacing method) Â visually estimated absolute tumor volume. As all visual estimates were strictly performed by one pathologist, inter-observer variability was not investigated in our study. Also, no morphometric approaches were carried out.
Follow-up
Median follow-up was 46.4 months (mean 48.8; range 10-116). In the after-care period, PSA determination and rectal palpation was performed at 4-monthly intervals for the first 2 years post-surgically and subsequently extended to 6-monthly intervals. The completion of the disease-free survival was defined as follows: detection of a postoperative PSA value X0.2 ng/ml, any local tumor relapse or distant metastases.
Statistical analysis
Possible associations between the clinical and pathological parameters and the tumor volume were analyzed by means of product-moment correlation according to Pearson (for interval-scaled and normal-distributed variables) and by means of rank correlation according to Spearman/Kendall (for ordinal-scaled variables). Both statistical tests were performed as a two-sided test. The correlation coefficient (r) embraces a spectrum from À1 to þ 1, with values o0.2 expressing a very low and values 40.9 expressing a very high correlation. A coefficient of rp0.5 describes a low correlation. PSA-free survival was calculated using the Kaplan-Meier method and differences were discriminated by means of log-rank test (with the significance level set at Po0.05). For the multivariate analysis, Cox proportional hazards regression method was used to define any independent influence of the absolute tumor volume and of the relative tumor volume on PSA-free survival
Results
Distribution of clinical and pathologic parameters and their correlation with the visually estimated tumor volume
Distributions of clinical and pathologic characteristics of the 528 patients are listed in Table 1 . The mean age of the patients at surgery was 63.8 (44-79) years. A total of 43% of the patients had a T1c carcinoma and more than 41% showed a preoperative PSA value of 410 ng/ml. A total of 17.4% of the patients presented with invasion of the seminal vesicles and/or lymph node . In 23% of the cases, surgical margins were histologically found to be positive.
In 14 patients (2.7%), a tumor volume of p0.5 cm 3 was visually estimated, and three of them showed an undifferentiated growth pattern of cancer (Gleason sum score X7). One of them was diagnosed with pN1. One ) and only 77% of them showed an organ-confined spread of cancer when assessed histopathologically. A significant correlation was found between tumor volume, relative tumor volume and clinical tumor stage, preoperative PSA value, the Gleason score, the pathologic tumor stage and the margin status. However, there was only a moderate correlation with the clinical tumor stage and the other criteria (ro0.2 and ro0.5, respectively; Table 2 ). We also found a moderate correlation between the absolute and the relative tumor volume (r ¼ 0.576; Po0.001).
Post-surgical outcome
A total of 101 patients (19%) came to clinical attention with PSA progression during follow-up. PSA-free survival rates of the entire study group after 1, 3 and 5 years were found to be 94.0, 84.0 and 78.3%, respectively. The average absolute and relative tumor volumes were significantly higher in patients with PSA progression (13.1 cm 3 , 28.2%) when compared to patients without PSA progression (5.2 cm 3 , 15.9%; each Po0.001). Among the 365 patients presenting with organ-confined prostate cancer, 43 patients experienced a tumor progress. These patients had a significantly larger average visually estimated absolute tumor volume (13.7 vs 4.3 cm 3 , P ¼ 0.003) and a significantly larger estimated relative tumor volume (18.8 vs 13.3%, P ¼ 0.029) in comparison with relapse-free patients presenting with organ-confined cancer. Considering the entire study group, PSAfree survival rates after 5 years were found to be 100% in patients estimated to have tumor volume less than 0.5 cm 3 , 87% in patients with an estimated tumor volume ranging between 0.6 and 4 cm 3 and 72.4% in patients with an estimated tumor volume ranging from 4.1-10 cm 3 , respectively. A total of 58.1% of the patients with an estimated absolute tumor volume in excess of 10 cm 3 did present with any tumor progress during a Estimation of tumor volume in prostate cancer M May et al post-surgical follow-up of 5 years (Po0.001; Figure 1 ). For the patients with relative tumor volumes in the range of 0-5, 5.1-10, 10.1-15, 15.1-25% and for those in excess of 25%, PSA-free survival rates were determined to be as follows: 90, 88, 87, 76 and 57%, respectively (Po0.001; Figure 2 ). When statistically compared, the first three intervals of the relative tumor volumes listed above failed to show any significant differences with regard to the assigned PSA-free survival rates (P40.5). In contrast, we found significant differences in PSA-free survival rates when comparing patients with relative tumor volumes between 15.1 and 25% with those in excess of 25% respectively. In summary, an estimated relative tumor volume in excess of 15% was found to be an adverse prognostic parameter.
Univariate analysis identified the criteria Gleason score, positive lymph nodes, pathologic tumor stage and preoperative PSA value to significantly influence PSA-free survival (each Po0.001). In contrast, surgical margins failed to be identified as prognostic means for predicting PSA-free survival (P ¼ 0.06).
Multivariate analysis of predictors of PSA recurrence
Because of the highly significant correlation between the visually estimated absolute and relative tumor volume, multivariate regression analysis of both parameters was carried out (Tables 3 and 4 ). The high-risk constellations of Gleason score X7(4 þ 3) and lymph node invasion were found to independently predict tumor progress. Follow-up showed a more than threefold increased risk (3.22-3.37) of PSA recurrence after prostatectomy in individuals assigned a Gleason score X7(4 þ 3) in comparison with patients presenting with Gleason scores p7(3 þ 4) ( Tables 3 and 4 ). An estimated relative tumor volume in excess of 25% was also determined to significantly and independently predict PSA recurrence (Table 4) . Although a visually estimated absolute tumor volume in excess of 10 cm 3 failed to be identified as an independent predictor of tumor progress, the risk of PSA recurrence in patients with estimated absolute tumor volumes in excess of 10 cm 3 appears nevertheless to be increased (Table 3) .
Discussion
Currently, there is a great deal of controversy as to whether or not determination of tumor volume should be recommended as a prognostic parameter for 
The study group guided by McNeal and Stamey [16] [17] [18] showed the biological course of prostate cancer to be closely related to the tumor volume. The authors postulated an absolute tumor volume in excess of 3 cm 3 to be predictive of an increased frequency of lymph node metastases (18 vs 0%), and also of skeletal metastases during follow-up after radical prostatectomy. 16, 17 Investigating a large study group comprising 379 patients diagnosed with prostate cancer, they also determined the tumor volume to be an independent predictor of disease progression after radical prostatectomy. 18 Blute et al.
19
found no positive association between tumor volume and disease progression when investigating a total of 76 patients diagnosed with organ-confined prostate cancer. However, the authors failed to provide concise information concerning the method applied for estimation of tumor volume in their study. Epstein et al. 9 analyzed the association between the absolute and the relative tumor volume, and the recurrence rate by evaluating a total of 185 men after radical prostatectomy. Although both parameters were found to be significantly higher in the subgroup of patients presenting with disease progression, both criteria failed to be identified as independent prognosticators with respect to disease progression in comparison with Gleason score and surgical margin status. In contrast, Eastham and Scardino 20 determined the tumor volume to be a significantly independent predictor of disease recurrence after radical prostatectomy when analyzing data pooled from the Baylor College of Medicine (Houston). However, the authors did not recommend measuring tumor volumes as a matter of routine as tumor volumes were only found to have a minor additional impact on disease progression, according to their investigation.
Several studies reported the visually estimated tumor volume to be in astonishing good accordance with the 'real' tumor volume determined by means of various morphometric approaches. [11] [12] [13] [14] [15] Two successive studies guided by the Washington University School of Medicine (St Louis) confirmed the visually estimated relative tumor volume to be an independent parameter for predicting oncological outcome after radical prostatectomy. 11, 21 A first smaller investigation with 73 patients was followed in 2000 by an investigation comprising 595 patients suffering from a clinically organ-limited prostate cancer who underwent radical prostatectomy. 11, 21 Despite of a low median follow-up of just 19 months, relative tumor volume was found to be an independent predictor of tumor progression together with the Gleason score and with the pathologic tumor stage. Patients assigned a relative tumor volume 415% showed a PSA-free survival of only 65% after 3 years post-surgically. 11 We confirmed this trend in our study. Patients visually estimated to have relative tumor volumes in the dimensions of 15, 1-25% and in excess of 25% showed PSA-free survivals of 76 and 57%, respectively, 5 years post-surgically. As determined by multivariate analysis, the high-risk constellations Gleason score X7(4 þ 3), positive lymph nodes and invasion of seminal vesicles, positive margins, a preoperative PSA value exceeding 20 ng/ml and relative tumor volumes in excess of 25% were found to independently predict disease progression (risk ratio: 2.15). Multivariate analysis carried out comprising identical factors failed to prove absolute tumor volumes 410 cm 3 to be significantly predictive of PSA recurrence (risk ratio: 1.28). Nevertheless, patients estimated to have absolute tumor volumes 410 cm 3 were found to present with unfavorable PSA-free survival rates when surveying a post-surgical period of 5 years (58%). Univariate analysis confirmed the influence of tumor volume to be highly significant (Po0.001). The population of patients investigated in our study (Table 1) can be regarded as being representative of current PSAdetected prostate cancers, although it should be kept in mind that there is some tendency towards lower mean relative tumor volumes (i.e., less than 25%) owing to the increasingly widespread use of PSA screening procedures among the male population.
The latest and greatest investigation addressing the issue under study demonstrates the impact caused by the selection of patients. In 2004, Kikuchi et al. 6 presented a study comprising a total of 1302 patients treated by radical prostatectomy between 1983 and 2000 with a median follow-up comparable to that of our investigation (46 months). This study found median tumor volumes to be significantly higher in patients with tumor progress than in patients without any tumor progress (3.13 vs 1.39 cm 3 , Po0.05). Although univariate analysis determined the tumor volume to be significantly associated with PSA-free survival, multivariate analysis failed to provide evidence of an independent influence on the PSA-free survival (risk ratio: 1.28; P ¼ 0.214). This investigation highlights that the patient populations pooled from American university hospitals recruited by means of PSA screening policies are not comparable with age-matched individuals pooled from areas without any PSA screening. The median tumor volume of the MSKCC series was 2.16 cm 3 before 1995, and was found to decrease in the period from 1995 to 2000 to 1.25 cm 3 . A total of 18.4% of the patients showed a tumor volume of less than 0.5 cm 3 and in 57% of the patients it was below 2 cm 3 . In our investigation, tumor volumes of o0.5, p0.5 and o2 cm 3 were found in 0.57% (n ¼ 3), 2.7% (n ¼ 14) and 15.3% (n ¼ 81) of the patients, respectively. The median absolute and relative tumor volumes assessed separately for the periods 1996-1999 and 2000-2003 did not show a significant difference (4 vs 4 cm 3 , 13.6 vs 13.3%; each P40.5). None of the 14 patients presenting with tumor volumes p0.5 cm 3 showed any PSA recurrence during follow-up. However, two of these patients were diagnosed with an undifferentiated tumor and one of them had an undifferentiated tumor with lymph node invasion.
Patients with a high risk of cancer progression should be identified as soon as possible because this group of patients certainly comprises candidates deriving benefit from adjuvant therapeutic regimes. This notion highlights the importance of parameters reliably predicting the risk of cancer progression in individual patients diagnosed with prostate cancer.
It has been pointed out that there are three potential limitations with regard to the meaningfulness of our investigation. At first, we did not compare our visual estimation of the tumor volume with planimetric methods making use of an image analysis system, although at present they represent the standard methods of determining tumor volume. Second, we are aware that Estimation of tumor volume in prostate cancer M May et al the median follow-up of our study is relatively short (46 months). Thus, further studies surveying an extensive post-surgical follow-up period are necessary in order to confirm our results. Finally, the lack of any PSA screening policy in our study merits emphasis and should be kept in mind when comparing our results with those derived from studies evaluating specimens sampled from regions characterized by widespread PSA screening of the population.
In conclusion, visual estimation of the tumor volume is simple and can be accomplished in all pathologic institutions because it does not require any special technical device. This approach represents a practical method, which was found to be a rewarding approach for deriving prognostic information regarding PSA-free survival after radical prostatectomy. Thus, we recommend its application by the pathologists as a matter of routine when processing prostatectomy specimens.
